Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study

News   Dec 28, 2012

 
Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study
 
 
 

RELATED ARTICLES

New Rapid Test for Valley Fever Should Help Reduce Diagnosis Delays

News

November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.

READ MORE

Inflammation Causes Chemo Brain

News

The research could lead to a new practice of identifying inflammatory biomarkers in cancer patients and then treating the inflammation with medications or exercise to improve cognition and other symptoms.

READ MORE

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE